Denali Therapeutics DNLI
NASDAQ DNLI
$20.81 -0.17 (-0.81%)
At close: Sep 29, 2026 · 4:00 PM EDT

Denali Therapeutics (DNLI) Non-Current Assets (2017 - 2026)

Updated

Denali Therapeutics' Non-Current Assets was $404.03 million in Q2 2026, up 74.5% from $231.54 million a year earlier and up 66.1% from the prior quarter.

Analysis

Denali Therapeutics (DNLI) Non-Current Assets (2017 - 2026) Analysis & Trends

At the end of FY2025, Non-Current Assets at Denali Therapeutics came in at $244.2 million, down 52.1% from FY2024.

  • Non-Current Assets shows a five-year compound annual growth rate of 17.6% (FY2020 to FY2025).
  • In earlier years, Non-Current Assets was $509.74 million in FY2024 (+467.8%), $89.78 million in FY2023 (+2.1%), $87.92 million in FY2022 (-82.7%) and $506.93 million in FY2021 (+366.7%).
  • The Q2 2026 figure marks the highest quarterly Non-Current Assets since Q4 2024.
  • Compared with a year earlier, Non-Current Assets was higher in three of the last eight quarters, with growth averaging 101.2%.
  • The best year-over-year quarter for Non-Current Assets over five years was Q1 2024 (growth of 621.7%); the worst was Q4 2022 (a decline of 82.7%).
  • Per Business Quant data, DNLI's Non-Current Assets in the three quarters before Q2 2026 was $243.27 million (Q1 2026), $244.2 million (Q4 2025) and $173.02 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 141.29 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 101.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 87.87 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 14.88 Bn
10 Denali Therapeutics 3.35 Bn 3.35 Bn 3.51 Mn 404.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 404.03 Mn
Mar 31, 2026 243.27 Mn
Dec 31, 2025 244.20 Mn
Sep 30, 2025 173.02 Mn
Jun 30, 2025 231.54 Mn
Mar 31, 2025 392.71 Mn
Dec 31, 2024 509.74 Mn
Sep 30, 2024 585.17 Mn
Jun 30, 2024 574.18 Mn
Mar 31, 2024 607.52 Mn
Dec 31, 2023 89.78 Mn
Sep 30, 2023 93.89 Mn
Jun 30, 2023 81.67 Mn
Mar 31, 2023 84.18 Mn
Dec 31, 2022 87.92 Mn
Sep 30, 2022 89.08 Mn
Jun 30, 2022 177.86 Mn
Mar 31, 2022 332.42 Mn
Dec 31, 2021 506.93 Mn
Sep 30, 2021 394.46 Mn
API Access

Denali Therapeutics Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=DNLI&period=max&api_key=YOUR_API_KEY